Emily holds a Ph.D. in Biochemistry from the University of Iowa and is currently a postdoctoral scholar at the University of Wisconsin-Madison. She graduated with a Masters in Chemistry from the Georgia Institute of Technology and holds a Bachelors in Biology and Chemistry from the University of Central Arkansas.
Emily is passionate about science communication, and, in her free time, writes and illustrates children’s stories.
Articles by Emily Malcolm
Recent Posts
- Cerebrovascular, cardiovascular disease risk seen higher in SSc
- FDA grants orphan drug status to BLR-200 for scleroderma
- 2 blood proteins may help detect lung issues in scleroderma patients
- Resilience may curb negative effects of feeling socially isolated: Study
- CABA-201 gets FDA orphan drug status as scleroderma treatment
- How scleroderma has changed my face, despite my best efforts
- T-helper cells may affect lung disease severity in SSc: StudyÂ
- Joint inflammation, health-related quality of life linked in SSc: Study
- Cognitive difficulties, malnutrition can be common with scleroderma
- Frequency of muscle disease in SSc shows need for biomarkers: Study